SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-052763
Filing Date
2022-10-05
Accepted
2022-10-05 16:36:13
Documents
1
Period of Report
2022-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3880
  Complete submission text file 0001209191-22-052763.txt   5402
Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
York Charles N II (Reporting) CIK: 0001655962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 221296108

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations